XTL Biopharmaceuticals Ltd. (XTLB)

0.9873 +0.02 (+1.67%) USD  |  NASDAQ  |  Jan 16, 16:00
0.91 -0.08 (-7.83%) After-Hours: 20:00
More

XTL Biopharmaceuticals EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for XTLB.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
Compugen Ltd. Upgrade
Can-Fite BioPharma Ltd. Upgrade
BiomX, Inc. Upgrade
Nasus Pharma Ltd. --
Regentis Biomaterials Ltd. --